Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.

Saved in:
Bibliographic Details
Title: Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.
Authors: Rojo F; Pathology Department, IIS-Fundación Jiménez Díaz University Hospital-UAM-CIBERONC, Madrid, Spain. frojo@fdj.es., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Fusco N; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Indraccolo S; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.; Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Vanden Bempt I; Department of Human Genetics, UZ Leuven and KU Leuven, Leuven, Belgium., Rocco EG; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Sardinha R; The Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden NHS Foundation Trust, London, UK., García-Murillas I; The Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden NHS Foundation Trust, London, UK.; The Breast Cancer Now Toby Robins Research Centre, Breast Cancer Research Division, The Institute of Cancer Research, London, UK., Adorisio R; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy., Boscolo Bragadin A; Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Carvajal N; Pathology Department, IIS-Fundación Jiménez Díaz University Hospital-UAM-CIBERONC, Madrid, Spain., Pepe F; Department of Public Health, University of Naples Federico II, Naples, Italy., Pérez-Buira S; Pathology Department, IIS-Fundación Jiménez Díaz University Hospital-UAM-CIBERONC, Madrid, Spain., Prieto-Potin I; Pathology Department, IIS-Fundación Jiménez Díaz University Hospital-UAM-CIBERONC, Madrid, Spain., Renders D; Department of Human Genetics, UZ Leuven and KU Leuven, Leuven, Belgium., Russo G; Department of Public Health, University of Naples Federico II, Naples, Italy., Scimone C; Department of Public Health, University of Naples Federico II, Naples, Italy., Swift C; The Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden NHS Foundation Trust, London, UK., Venetis K; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy., Zazo S; Pathology Department, IIS-Fundación Jiménez Díaz University Hospital-UAM-CIBERONC, Madrid, Spain., Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 Jun 17. Date of Electronic Publication: 2026 Jun 17.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-2000
DOI:10.1007/s40291-026-00850-9